PALI

Palisade Bio, Inc. Common Stock (PALI)

NASDAQ: PALIUSD
1.90 USD
+0.02 (+0.80%)
🟢LIVE (AS OF 03:39 PM EDT)
🟢Market: OPEN
Open?$1.85
High?$1.92
Low?$1.79
Prev. Close?$1.88
Volume?1.9M
Avg. Volume?4.0M
VWAP?$1.87
Rel. Volume?0.48x
Bid / Ask
Bid?$1.89 × 1.3K
Ask?$1.90 × 1.9K
Spread?$0.01
Midpoint?$1.90
Valuation & Ratios
Market Cap?312.2M
Shares Out?165.9M
Float?148.2M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?2.41
EPS?-$0.10
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?28.95Strong
Quick Ratio?28.95Strong
Cash Ratio?28.77Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
2.41CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-9.9CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-13.0%WEAK
ROA?
-12.5%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$178.9M
Related Companies
Loading...
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
312.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900